Cargando…

Fragment-based virtual screening identifies a first-in-class preclinical drug candidate for Huntington’s disease

Currently, there are no therapies available to modify the disease progression of Huntington’s disease (HD). Recent clinical trial failures of antisense oligonucleotide candidates in HD have demonstrated the need for new therapeutic approaches. Here, we developed a novel in-silico fragment scanning a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galyan, Simon Marius, Ewald, Collin Y., Jalencas, Xavier, Masrani, Shyam, Meral, Selin, Mestres, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668931/ https://www.ncbi.nlm.nih.gov/pubmed/36385140 http://dx.doi.org/10.1038/s41598-022-21900-2

Ejemplares similares

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease
por: Rusz, Jan, et al.
Publicado: (2014)

Recent Trends in Detection of Huntingtin and Preclinical Models of Huntington's Disease
por: Mantha, Neelima, et al.
Publicado: (2014)

Temporal Phenotypic Changes in Huntington’s Disease Models for Preclinical Studies
por: St-Cyr, Sophie, et al.
Publicado: (2022)

Regulation of Hippocampal cGMP Levels as a Candidate to Treat Cognitive Deficits in Huntington’s Disease
por: Saavedra, Ana, et al.
Publicado: (2013)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

One-year changes in brain microstructure differentiate preclinical Huntington's disease stages
por: Pflanz, Chris Patrick, et al.
Publicado: (2019)

Where are the fragments of the virtual photon ?
por: González, A M, et al.
Publicado: (1973)

Identifying enriched drug fragments as possible candidates for metabolic engineering
por: Sharma, Sunandini, et al.
Publicado: (2016)

Developing Potential Candidates of Preclinical Preeclampsia
por: Founds, Sandra, et al.
Publicado: (2015)

Selecting the Next Class: The “Virtual Orthopaedic Rotation”
por: Yellin, Joseph L., et al.
Publicado: (2022)

Preclinical and Clinical Investigations of Mood Stabilizers for Huntington's Disease: What Have We Learned?
por: Scheuing, Lisa, et al.
Publicado: (2014)

Luciferase fragment complementation imaging in preclinical cancer studies
por: Lake, Madryn C., et al.
Publicado: (2014)

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
por: Träger, Ulrike, et al.
Publicado: (2015)

Association of Huntington's disease and schizophrenia-like psychosis in a Huntington's disease pedigree
por: Corrêa, Bernardo Barahona, et al.
Publicado: (2006)

Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development?
por: Leuchter, Michael K., et al.
Publicado: (2017)

Targeted Depletion of Primary Cilia in Dopaminoceptive Neurons in a Preclinical Mouse Model of Huntington’s Disease
por: Mustafa, Rasem, et al.
Publicado: (2019)

Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3
por: Tornatore, Laura, et al.
Publicado: (2019)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

Virtual Shadowing Program for Preclinical Medical Students
por: Saini, Prashant, et al.
Publicado: (2021)

A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin
por: Damiano, Maria, et al.
Publicado: (2013)

A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
por: Li, Endan, et al.
Publicado: (2023)

Binding-Site Assessment by Virtual Fragment Screening
por: Huang, Niu, et al.
Publicado: (2010)

An algorithm for fragment-aware virtual network reconfiguration
por: Liu, Xinbo, et al.
Publicado: (2018)

Preclinical Testing of a Vaccine Candidate against Tularemia
por: Suresh, Ragavan Varadharajan, et al.
Publicado: (2015)

Core Outcome Measures in Preclinical Assessment of Candidate Analgesics
por: Negus, S. Stevens
Publicado: (2019)

Latent class analysis identifies functional decline with Amsterdam IADL in preclinical Alzheimer's disease
por: Villeneuve, Sarah-Christine, et al.
Publicado: (2019)

Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
por: Erickson, Claire M., et al.
Publicado: (2021)

Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013)

Preclinical evaluation of lime juice as a topical microbicide candidate
por: Fletcher, Patricia S, et al.
Publicado: (2008)

Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
por: Yang, Chih-Sheng, et al.
Publicado: (2023)

An implementation of virtual white board using open CV for virtual classes
por: Aswin Kumer, S.V., et al.
Publicado: (2021)

Preclinical Modeling of DCD Class III Donation: Paving the Way for the Increased Use of This Challenging Donor Type
por: Soussi, David, et al.
Publicado: (2019)

Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates
por: Schut, Menno H., et al.
Publicado: (2017)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition
por: Wyllie, Susan, et al.
Publicado: (2019)

Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosis
por: Gao, Chao, et al.
Publicado: (2016)

Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019)

Transplanted organoids empower human preclinical assessment of drug candidate for the clinic
por: Westerling-Bui, Amy D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4tutl17kej3i2bi1abjo6jtka